Innovative Eyewear Q1 Revenue Surges, Losses Narrow

TL;DR

Innovative Eyewear Q1 revenue up 200%+, losses shrinking. Looks promising.

AI Summary

Innovative Eyewear Inc. filed an S-1/A amendment on June 11, 2024, detailing its financial performance. For the first quarter of 2024, the company reported revenue of $1.04 million, a significant increase from $0.34 million in the same period of 2023. Net losses narrowed to $1.1 million in Q1 2024 from $1.5 million in Q1 2023, indicating improving operational efficiency.

Why It Matters

This filing provides insight into Innovative Eyewear's growth trajectory and financial health, crucial for investors assessing the company's potential in the competitive eyewear market.

Risk Assessment

Risk Level: medium — While revenue growth is strong, the company is still operating at a net loss, indicating ongoing financial risk.

Key Numbers

• $1.04M — Q1 2024 Revenue (Significant year-over-year growth)
• $0.34M — Q1 2023 Revenue (Baseline for comparison)
• $1.1M — Q1 2024 Net Loss (Narrowing losses indicate improved efficiency)
• $1.5M — Q1 2023 Net Loss (Previous period loss for comparison)

Key Players & Entities

• Innovative Eyewear Inc. (company) — Filer of the S-1/A amendment
• 0001829126-24-004084 (dollar_amount) — Accession Number for the filing
• 20240611 (date) — Filing date
• $1.04 million (dollar_amount) — Revenue for Q1 2024
• $0.34 million (dollar_amount) — Revenue for Q1 2023
• $1.1 million (dollar_amount) — Net loss for Q1 2024
• $1.5 million (dollar_amount) — Net loss for Q1 2023

FAQ

Key Financial Figures

• $0.00001 — 3,782 shares of common stock, par value $0.00001 per share, of Innovative Eyewear, Inc.
• $0.244 — stor Warrants") at an exercise price of $0.244 per share originally issued by us on Ma
• $0.305 — pril Warrants") at an exercise price of $0.305 per share originally issued by us on Ma
• $0.475 — stor Warrants") at an exercise price of $0.475 per share originally issued by us on Ma
• $0.5938 — the "Warrants") at an exercise price of $0.5938 per share originally issued by us on Ma
• $0.95 — rted sale price of our common stock was $0.95 per share. Following effectiveness of
• $35.2 billion — eyewear in the U.S. is projected to be $35.2 billion in 2024. The market for digital assista
• $4.5 billion — rapidly worldwide, and is projected at $4.5 billion in revenue in 2023. We view the popular
• $249 M — e audio quality at a higher list price ($249 MSRP) than Lucyd Lyte 2.0 ($199). However
• $199 — price ($249 MSRP) than Lucyd Lyte 2.0 ($199). However, Bose has recently announced
• $329 — e Bluetooth eyewear space, offered at a $329 - $389 list price. Not available direct
• $389 — ooth eyewear space, offered at a $329 - $389 list price. Not available directly from
• $149 — and our glasses are more affordable at $149 - $199. Snapchat Spectacles . This is

Filing Documents

• innovativeeye_s1a1.htm (S-1/A) — 1842KB
• innovativeeye_ex23-1.htm (EX-23.1) — 3KB
• img_001.jpg (GRAPHIC) — 23KB
• img_002.jpg (GRAPHIC) — 42KB
• fin_001.jpg (GRAPHIC) — 4KB
• fin_002.jpg (GRAPHIC) — 3KB
• 0001829126-24-004084.txt ( ) — 6862KB
• lucy-20240331.xsd (EX-101.SCH) — 45KB
• lucy-20240331_cal.xml (EX-101.CAL) — 78KB
• lucy-20240331_def.xml (EX-101.DEF) — 171KB
• lucy-20240331_lab.xml (EX-101.LAB) — 310KB
• lucy-20240331_pre.xml (EX-101.PRE) — 318KB
• innovativeeye_s1a1_htm.xml (XML) — 798KB

Use of Proceeds

Use of Proceeds 40 Determination of Offering Price 41 Market Information for Common Stock and Dividend Policy 42

Management's Discussion and Analysis of Financial Condition and Results of Operation

Management's Discussion and Analysis of Financial Condition and Results of Operation 43

Business

Business 61 Management 83

Executive Compensation

Executive Compensation 87 Certain Relationships and Related Transactions 94

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 96

Description of Securities Being Registered

Description of Securities Being Registered 98 Selling Stockholders 101 Plan of Distribution 103 Experts 105 Legal Matters 105 Where You Can Find More Information 105 Index to Financial Statements F-1 i Table of Contents Please read this prospectus carefully. It describes our business, our financial condition and our results of operations. We have prepared this prospectus so that you will have the information necessary to make an informed investment decision. You should rely only on the information contained in this prospectus. We have not authorized anyone to provide you with any information or to make any representations about us, the securities being offered pursuant to this prospectus or any other matter discussed in this prospectus, other than the information and representations contained in this prospectus. If any other information or representation is given or made, such information or representation may not be relied upon as having been authorized by us. The information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of our common stock. Neither the delivery of this prospectus nor any distribution of securities in accordance with this prospectus shall, under any circumstances, imply that there has been no change in our affairs since the date of this prospectus. This prospectus will be updated and made available for delivery to the extent required by the federal securities laws. We further note that the representations, warranties and covenants made by us in any document that is filed as an exhibit to the registration statement of which this prospectus is a part were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a representation, warranty or covenant to you. Moreover, such represent

View Full Filing

View this S-1/A filing on SEC EDGAR